These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2. Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG mBio; 2020 Sep; 11(5):. PubMed ID: 32913009 [TBL] [Abstract][Full Text] [Related]
4. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics. Cheemarla NR; Watkins TA; Mihaylova VT; Wang B; Zhao D; Wang G; Landry ML; Foxman EF J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34128960 [TBL] [Abstract][Full Text] [Related]
6. Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2. Agrawal S; Salazar J; Tran TM; Agrawal A Front Immunol; 2021; 12():739757. PubMed ID: 34745109 [TBL] [Abstract][Full Text] [Related]
7. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity. Vono M; Huttner A; Lemeille S; Martinez-Murillo P; Meyer B; Baggio S; Sharma S; Thiriard A; Marchant A; Godeke GJ; Reusken C; Alvarez C; Perez-Rodriguez F; Eckerle I; Kaiser L; Loevy N; Eberhardt CS; Blanchard-Rohner G; Siegrist CA; Didierlaurent AM Cell Rep; 2021 Oct; 37(1):109773. PubMed ID: 34587479 [TBL] [Abstract][Full Text] [Related]
8. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age. Lieberman NAP; Peddu V; Xie H; Shrestha L; Huang ML; Mears MC; Cajimat MN; Bente DA; Shi PY; Bovier F; Roychoudhury P; Jerome KR; Moscona A; Porotto M; Greninger AL PLoS Biol; 2020 Sep; 18(9):e3000849. PubMed ID: 32898168 [TBL] [Abstract][Full Text] [Related]
9. Fortifying immunity: PLSCR1 picks battle against SARS-CoV-2. Li M Cell Host Microbe; 2023 Sep; 31(9):1417-1419. PubMed ID: 37708846 [TBL] [Abstract][Full Text] [Related]
10. A hybrid discrete-continuum model of immune responses to SARS-CoV-2 infection in the lung alveolar region, with a focus on interferon induced innate response. Aristotelous AC; Chen A; Forest MG J Theor Biol; 2022 Dec; 555():111293. PubMed ID: 36208668 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells. Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952 [TBL] [Abstract][Full Text] [Related]
13. Human Nasal and Lung Tissues Infected Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170 [TBL] [Abstract][Full Text] [Related]
14. Interferon response and profiling of interferon response genes in peripheral blood of vaccine-naive COVID-19 patients. Huang B; Huang J; Chiang NH; Chen Z; Lui G; Ling L; Kwan MYW; Wong JSC; Mak PQ; Ling JWH; Lam ICS; Ng RWY; Wang X; Gao R; Hui DS; Ma SL; Chan PKS; Tang NLS Front Immunol; 2023; 14():1315602. PubMed ID: 38268924 [TBL] [Abstract][Full Text] [Related]
15. An Evaluation of Type 1 Interferon Related Genes in Male and Female-Matched, SARS-CoV-2 Infected Individuals Early in the COVID-19 Pandemic. Huecksteadt TP; Myers EJ; Aamodt SE; Trivedi S; Warren KJ Viruses; 2024 Mar; 16(3):. PubMed ID: 38543837 [TBL] [Abstract][Full Text] [Related]
16. Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options. Znaidia M; Demeret C; van der Werf S; Komarova AV Viruses; 2022 Jun; 14(6):. PubMed ID: 35746718 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection. Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442 [TBL] [Abstract][Full Text] [Related]
18. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection. Sohn SY; Hearing J; Mugavero J; Kirillov V; Gorbunova E; Helminiak L; Mishra S; Mackow E; Hearing P; Reich NC; Kim HK mBio; 2021 Dec; 12(6):e0275621. PubMed ID: 34724828 [TBL] [Abstract][Full Text] [Related]
19. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals. Prokop JW; Hartog NL; Chesla D; Faber W; Love CP; Karam R; Abualkheir N; Feldmann B; Teng L; McBride T; Leimanis ML; English BK; Holsworth A; Frisch A; Bauss J; Kalpage N; Derbedrossian A; Pinti RM; Hale N; Mills J; Eby A; VanSickle EA; Pageau SC; Shankar R; Chen B; Carcillo JA; Sanfilippo D; Olivero R; Bupp CP; Rajasekaran S Front Immunol; 2021; 12():694243. PubMed ID: 34335605 [TBL] [Abstract][Full Text] [Related]
20. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model. Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL; mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]